Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Adams

Showing results (751-760 of 831) with videos related to

Pageof 84
Sort By:
Perspectives in Biology and Medicine|January 13, 2015
Letters to and from the editorJ B Gibson, C G Mascie-Taylor, J N Thompson, et al.
Journal of Cardiac Failure|March 9, 2010
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failureLarry A Allen, G Michael Felker, Mandeep R Mehra, et al.
Journal of Cardiac Failure|January 12, 2023
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart FailureJosephine Harrington, Andrew B Nixon, Melissa A Daubert, et al.
American Heart Journal|December 15, 2010
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams, Mandeep R Mehra, Ron M Oren, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Dose Response of β-Blockers in Adrenergic Receptor Polymorphism GenotypesKishan S Parikh, Mona Fiuzat, Gordon Davis, et al.
Journal of the American College of Cardiology|January 22, 2011
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failureAndrew Sherwood, James A Blumenthal, Alan L Hinderliter, et al.
Circulation. Heart Failure|September 17, 2015
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF TrialsG Michael Felker, Robert J Mentz, Kirkwood F Adams, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
European Journal of Heart Failure|January 29, 2013
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trialMihai Gheorghiade, Kanan Patel, Gerasimos Filippatos, et al.
JACC. Heart Failure|September 30, 2017
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION StudyAbhinav Sharma, Susanna R Stevens, Joseph Lucas, et al.
Pageof 84

Showing results (751-760 of 831) with videos related to

Sort By:
Pageof 84
Perspectives in Biology and Medicine|January 13, 2015
Letters to and from the editorJ B Gibson, C G Mascie-Taylor, J N Thompson, et al.
Journal of Cardiac Failure|March 9, 2010
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failureLarry A Allen, G Michael Felker, Mandeep R Mehra, et al.
Journal of Cardiac Failure|January 12, 2023
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart FailureJosephine Harrington, Andrew B Nixon, Melissa A Daubert, et al.
American Heart Journal|December 15, 2010
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams, Mandeep R Mehra, Ron M Oren, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Dose Response of β-Blockers in Adrenergic Receptor Polymorphism GenotypesKishan S Parikh, Mona Fiuzat, Gordon Davis, et al.
Journal of the American College of Cardiology|January 22, 2011
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failureAndrew Sherwood, James A Blumenthal, Alan L Hinderliter, et al.
Circulation. Heart Failure|September 17, 2015
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF TrialsG Michael Felker, Robert J Mentz, Kirkwood F Adams, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
European Journal of Heart Failure|January 29, 2013
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trialMihai Gheorghiade, Kanan Patel, Gerasimos Filippatos, et al.
JACC. Heart Failure|September 30, 2017
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION StudyAbhinav Sharma, Susanna R Stevens, Joseph Lucas, et al.
Pageof 84